https://dealroom.co/news/122565-govini-hits-100m-arr-challenging-palantir-and-anduril-in-defense-moderni/ 2025-10-12T21:29:55+00:00 https://dealroom.co/news/122564-polymarket-faces-insider-trading-concerns-after-nobel-prize-windfall/ 2025-10-12T19:46:32+00:00 https://dealroom.co/news/122555-supabase-used-by-55-of-yc-companies/ 2025-10-11T10:08:36+00:00 https://dealroom.co/news/122548-prediction-markets-attract-big-capital-as-kalshi-scales-abroad/ 2025-10-10T14:03:04+00:00 https://dealroom.co/news/122540-ex-deepmind-founders-raise-2b-for-reflection-to-rival-openai-and-deepsee/ 2025-10-09T23:54:49+00:00 https://dealroom.co/news/122538-ascenta-capital-closes-325m-war-chest-to-hunt-the-next-biotech-unicorns/ 2025-10-09T18:14:17+00:00 https://dealroom.co/news/122536-expedition-therapeutics-secures-165m-to-develop-next-gen-copd-therapy/ 2025-10-09T16:53:44+00:00 https://dealroom.co/news/122530-np-hard-ventures-launches-25m-fund-to-back-europes-deep-tech-builders/ 2025-10-09T13:51:27+00:00 https://dealroom.co/news/122529-akero-therapeutics-from-breakthrough-hope-to-5-2-billion-exit/ 2025-10-09T13:37:41+00:00 https://dealroom.co/news/122522-ai-agent-startup-n8n-nets-2-5-billion-valuation-with-backing-from-nvidia/ 2025-10-09T11:19:07+00:00 https://dealroom.co/news/122520-base-power-aims-to-redefine-energy-infrastructure-with-1b-boost/ 2025-10-09T09:30:11+00:00 https://dealroom.co/news/122517-biotech-startup-arthrosi-advances-late-stage-gout-drug-with-153m-raise/ 2025-10-09T02:31:06+00:00 https://dealroom.co/news/122513-stoke-space-aims-for-the-next-stage-in-reusable-rockets/ 2025-10-08T21:04:40+00:00 https://dealroom.co/news/122512-amd-strikes-unusual-deal-with-openai-using-its-own-stock-to-fund-chip-sa/ 2025-10-08T20:28:17+00:00 https://dealroom.co/news/122509-from-paperwork-to-platform-evenups-mission-to-modernize-justice/ 2025-10-08T14:06:21+00:00 https://dealroom.co/news/122508-qualcomm-acquires-arduino-a-new-chapter-in-open-hardware/ 2025-10-08T13:08:17+00:00 https://dealroom.co/news/122507-ubers-global-operator-bets-on-europe-pierre-dimitri-gore-coty-joins-plur/ 2025-10-08T13:05:02+00:00 https://dealroom.co/news/122504-abb-sells-robotics-arm-to-softbank-for-5-4b-in-strategic-realignment/ 2025-10-08T12:32:30+00:00 https://dealroom.co/news/122496-meet-the-startup-with-3-5b-in-deals-before-a-single-trial/ 2025-10-07T20:29:22+00:00 https://dealroom.co/news/122494-from-fringe-to-finance-ice-bets-on-polymarkets-comeback/ 2025-10-07T19:17:28+00:00 https://dealroom.co/news/122492-northlane-capital-partners-closes-oversubscribed-750m-fund-reinforcing-m/ 2025-10-07T18:06:44+00:00 https://dealroom.co/news/122491-clickhouse-extends-series-c-amid-rapid-revenue-growth/ 2025-10-07T17:30:03+00:00 https://dealroom.co/news/122487-sugar-free-capital-backing-mits-next-gen-technical-founders/ 2025-10-07T16:29:13+00:00 https://dealroom.co/news/122485-betting-on-ai-to-transform-insurance-jonathan-crystals-venture-play/ 2025-10-07T13:47:38+00:00 https://dealroom.co/news/122484-trusk-secures-350k-to-advance-autonomy-for-military-interceptor-drones/ 2025-10-07T13:10:41+00:00 https://dealroom.co/news/122483-radical-ventures-closes-650m-fund-to-back-next-gen-ai-startups/ 2025-10-07T12:03:36+00:00 https://dealroom.co/news/122478-firefly-aerospace-strengthens-defense-footprint-with-855m-scitec-deal/ 2025-10-06T20:03:52+00:00 https://dealroom.co/news/122477-trogenix-lands-95-to-deliver-curative-therapies-for-aggressive-cancers/ 2025-10-06T19:10:24+00:00 https://dealroom.co/news/122470-nanophoria-raises-record-83-5m-series-a-for-nanotech-heart-failure-thera/ 2025-10-06T15:27:44+00:00 https://dealroom.co/news/122467-lauxera-capital-closes-400m-healthtech-fund-for-global-expansion/ 2025-10-06T14:09:56+00:00 https://dealroom.co/news/122465-raise-reaches-unicorn-status-with-120m-round-to-expand-dhan-investing-pl/ 2025-10-06T13:16:32+00:00